glp-1 drugs and breast cancer Researchers from Penn Medicine found that women taking are less likely to be diagnosed with cancer., @drcelinegounder breaks down the study’s findings whether the drugs caused GLP-1 Drugs and Breast Cancer:
Description
10,11,12 Multiple studies have found that the BMD of AN patients in the active phase is lower than that of healthy controls, with a decrease of 16% in the lumbar spine, 18% in the femoral neck, and 23% in the total hip

There are continuous investments in healthcare innovation and also strategic collaborations , that help support long-term market growth

New weight loss drug dubbed 'triple G' shows promise: What to know about retatrutide A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed promising results in new data released Thursday by its maker, Eli Lilly

FDA (2008)
drug repurposing

The most recent studies demonstrate the advantage of sinus rhythm control and maintenance among HFpEF patients